Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity

Journal of Endocrinological Investigation

Volumn 27, Issue 6, 2004, Pages 541-547

  Vicennati, V ^a   Ceroni, L ^a   Gagliardi, L ^a   Pagotto, U ^a   Gambineri, A ^a   Genghini, S ^a   Pasquali, Renato ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Alprazolam; Arginine vasopressin; HPA axis; Obesity; Urine free cortisol

Indexed keywords

ALPRAZOLAM; ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CREATININE; HYDROCORTISONE; VASOPRESSIN;

ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CREATININE URINE LEVEL; DRUG INHIBITION; FEEDBACK SYSTEM; FEMALE; HORMONE INHIBITION; HORMONE RESPONSE; HORMONE SENSITIVITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW DRUG DOSE; OBESITY; PHENOTYPE; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; URINE LEVEL;

EID: 4544377737     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347476     Document Type: Article

References (37)

1. Orth DN. Corticotropin-releasing hormone in humans. Endocr Rev 1992, 13: 164-91.
2. Plotsky PM. Pathways to the secretion of adrenocorticotropin: a view from the portal. J Neuroendocrinol 1991, 3: 1-9.
3. DeBold CR, Sheldon WR, DeCherney GS, et al. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest 1984, 73: 533-8.
4. Caraty A, Grino M, Locatelli A, et al. Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams. J Clin Invest 1999, 85: 1716-21.
5. Canny BJ, Funder JW, Clarke IJ. Glucocorticoids regulate ovine hypophysial portal levels of corticotropin-releasing factor and arginine vasopressin in a stress-specific manner. Endocrinology 1989, 125: 2532-9.
6. Jia LG, Canny BJ, Orth DN, Leong DA. Distinct classes of corticotropes mediate corticotropin-releasing hormone- and arginine vasopressin-stimulated adrenocorticotropin release. Endocrinology 1991, 128: 197-203.
7. Schwartz J, Cherny R. Intercellular communication within the anterior pituitary influencing the secretion of hypophysial hormones. Endocr Rev 1992, 13: 453-75.
8. Abou-Samra AB, Harwood JP, Manganiello VC, Catt KJ, Aguilera G. Phorbol 12-myristate 13-acetate and vasopressin potentiate the effect of corticotropin-releasing factor on cyclic AMP production in rat anterior pituitary cells. Mechanisms of action. J Biol Chem 1987, 262: 1129-36.
9. Pasquali R, Cantobelli S, Casimirri F, et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993, 77: 341-6.
10. Pasquali R, Anconetani B, Chattat R, et al. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. Metabolism 1996, 45: 351-6.
11. Vicennati V, Pasquali R. Abnormalities of the hypothalamic-pituitary-adrenal axis in women with the abdominal obesity and relationship with insulin resistance: evidence for a central and peripheral alteration. J Clin Endocrinol Metab 2000, 24: 416-22.
12. Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998, 83: 1853-9.
13. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 2001, 2: 73-86.
14. Dallman MF, Bhatnagar S. Chronic stress and energy balance: role of the hypothalamic-pituitary-adrenal axis. In: Mc Ewen BS, ed. Handbook of Physiology: the environment. Washington, DC: American Physiological Society.
15. Shively C, Clarkson T. Regional obesity and coronary atherosclerosis in females: a non-human primate model. Acta Med Scand 1989, 723: 71-8.
16. Dawson GW, Jue SG, Brogden RN. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. Drugs 1984, 27: 132-47.
17. Kalogeras KT, Calogero AE, Kuribayiashi T, et al. In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications. J Clin Endocrinol Metab 1990, 70: 1462-71.
18. Arvat E, Giordano R, Grottoli S, Ghigo E. Benzodiazepines and anterior pituitary function. J Endocrinol Invest 2002, 25: 735-47.
19. Lopez AL, Kathol RG, Noyes R Jr. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Psychoneuroendocrinology 1990, 15: 23-8.
20. Breier A, Davis O, Buchanan R, Holmes C, Pickar D, Goldstein DS. Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans. Biol Psych 1992, 32: 880-90.
21. Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans. J Clin Endocrinol Metab 1994, 79: 140-4.
22. Arvat E, Maccagno B, Ramunni J, et al. The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effects of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans. J Clin Endocrinol Metab 1999, 84: 2611-5.
23. Zemishlany Z, McQueeney R, Gabriel SM, Davidson M. Neuroendocrine and monoaminergic responses to acute administration of alprazolam in normal subjects. Neuroendocrinology 1990, 23: 124-8.
24. Arai K, Takebe K. Corticotropin response to combined administration of human corticotropin-releasing hormone and small-dose arginine vasopressin in normal subjects. Metabolism 1991, 40: 1088-91.
25. The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998, 21: S5-S19.
26. Krug SE, Laughlin JE. Questionario di autovalutazione C.D.Q (IPAT Depression Scale). Organizzazioni Speciali, Firenze, 1979.
27. Fava GA. Assessing depressive symptoms across cultures. Italian validation of the CES-D self-rating scale. J Clin Psychol 1983, 39: 249-52.
28. Report of a WHO Consultation on Obesity. Preventing and managing the global epidemic. Geneva: WHO/NUT/NCD;1997, 98.1.
29. Abernethy DR, Greenblatt DJ, Divoll M, Shaker RI. Pharmacokinetics of alprazolam. J Clin Psych 1983, 44: 45-7.
30. Pasquali R, Vicennati V. The abdominal obesity phenotype and insulin resistance are associated with abnormalities of the hypothalamic-pituitary-adrenal axis in humans. Horm Metab Res 2000, 32: 521-5.
31. Walker BR. Activation of the hypothalamic-pituitary-adrenal axis: cause or consequence? Growth Horm IGF Res 2001, 11 Suppl A: S91-95.
32. Pasquali R, Ambrosi B, Armanini D, et al. Study Group on Obesity of the Italian Society of Endocrinology. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab 2002, 87: 166-75.
33. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr Rev 1993, 14: 222-40.
34. Yanagibashi K, Ohno Y, Nakamichi N, et al. Peripheral-type benzodiazepine receptors are involved in the regulation of cholesterol side chain cleavage in adrenocortical mitochondria. J Biochem 1989, 106: 1026-9.
35. Bratel T, Wennlund A, Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment. Respir Med 1999, 93: 1-7.
36. Duclos M, Corcuff JB, Etcheverry N, Rashedi M, Tabarin A, Roger P Abdominal obesity increases overnight cortisol excretion. J Clin Invest 1983, 22: 465-71.
37. Pasquali R, Biscotti D, Spinucci G, et al. Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution. Clin Endocrinol (oxf) 1998, 48: 603-12.